Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.
2.

Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.

Mainous AG, Tanner RJ, Shorr RI, Limacher MC.

J Am Heart Assoc. 2014 Jul 14;3(4). pii: e000989. doi: 10.1161/JAHA.114.000989.

3.

Recommended use of aspirin and other antiplatelet medications among adults--National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008.

George MG, Tong X, Sonnenfeld N, Hong Y; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2012 Jun 15;61(2):11-8.

PMID:
22695458
4.

Outpatient management of heart failure in the United States, 2006-2008.

Mosalpuria K, Agarwal SK, Yaemsiri S, Pierre-Louis B, Saba S, Alvarez R, Russell SD.

Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.

5.

A national survey on aspirin patterns of use and persistence in community outpatients in Italy.

Filippi A, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):695-703. doi: 10.1177/1741826710397850. Epub 2011 Mar 1.

PMID:
21450601
6.

Patient, Physician, and Practice Characteristics Associated with Cardiovascular Disease Preventive Care for Women.

Dean CA, Arnold LD, Hauptman PJ, Wang J, Elder K.

J Womens Health (Larchmt). 2017 May;26(5):491-499. doi: 10.1089/jwh.2015.5613. Epub 2017 Feb 27.

PMID:
28437218
7.

Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women.

Rivera CM, Song J, Copeland L, Buirge C, Ory M, McNeal CJ.

J Womens Health (Larchmt). 2012 Apr;21(4):379-87. doi: 10.1089/jwh.2011.2990. Epub 2012 Feb 3.

PMID:
22303820
8.

Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study.

Liddy C, Singh J, Hogg W, Dahrouge S, Deri-Armstrong C, Russell G, Taljaard M, Akbari A, Wells G.

BMC Cardiovasc Disord. 2012 Sep 12;12:74. doi: 10.1186/1471-2261-12-74.

9.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

10.

Statins for secondary cardiovascular disease prevention for older primary care patients.

Niska R, Han B.

J Natl Med Assoc. 2009 Jul;101(7):705-10.

PMID:
19634592
11.

National study of physician awareness and adherence to cardiovascular disease prevention guidelines.

Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL.

Circulation. 2005 Feb 1;111(4):499-510.

12.

Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study.

Homer K, Boomla K, Hull S, Dostal I, Mathur R, Robson J.

Br J Gen Pract. 2015 Aug;65(637):e538-44. doi: 10.3399/bjgp15X686113.

13.

Aspirin use among adults aged 40 and older in the United States: results of a national survey.

Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM.

Am J Prev Med. 2007 May;32(5):403-407.

PMID:
17478266
14.
15.

Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.

Grimes RT, Ensor J, Bennett K, Henman MC.

Prim Care Diabetes. 2016 Aug;10(4):237-43. doi: 10.1016/j.pcd.2015.11.002. Epub 2015 Dec 1.

PMID:
26654852
16.

Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.

Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS.

J Am Coll Cardiol. 2015 Jan 20;65(2):111-21. doi: 10.1016/j.jacc.2014.10.035.

17.

Screening, treatment, and control of hypertension in US private physician offices, 2003-2004.

Ma J, Stafford RS.

Hypertension. 2008 May;51(5):1275-81. doi: 10.1161/HYPERTENSIONAHA.107.107086. Epub 2008 Mar 17.

18.

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA.

JAMA. 2016 May 3;315(17):1864-73. doi: 10.1001/jama.2016.4151.

PMID:
27139059
19.

Trends in Ambulatory Management of Urinary Incontinence in Women in the United States.

Forde JC, Chughtai B, Cea M, Stone BV, Te A, Bishop TF.

Female Pelvic Med Reconstr Surg. 2017 Jul/Aug;23(4):250-255. doi: 10.1097/SPV.0000000000000365.

PMID:
28106650
20.

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.

Fleetcroft R, Schofield P, Ashworth M.

BMC Health Serv Res. 2014 Sep 20;14:414. doi: 10.1186/1472-6963-14-414.

Supplemental Content

Support Center